Does acid suppression alter progression in Barrett’s esophagus?

Castell, Donald O.
January 2003
American Journal of Gastroenterology;Jan2003, Vol. 98 Issue 1, p213
Academic Journal
No abstract available.


Related Articles

  • Molecular mechanisms of acid exposure in Barrett�s esophagus. Souza, R. F. // Inflammopharmacology;Jun2007, Vol. 15 Issue 3, p95 

    Esophageal adenocarcinoma is one of the most deadly gastrointestinal tumors. Gastroesophageal reflux has been established as a major risk factor for esophageal adenocarcinoma and Barrett�s esophagus, the condition in which the normal squamous cells of the esophagus are replaced by...

  • Continuing Medical Education Questions: July 2010. DeVault, Kenneth R.; Wang, Yinghong; Kim, Karen C.; Atreja, Ashish; Chiang, Dian // American Journal of Gastroenterology;Jul2010, Vol. 105 Issue 7, p1503 

    A quiz concerning the progression in Barrett's esophagus.

  • Management of Barrett's Esophagus. VELANOVICH, VIC // American Surgeon;Nov2012, Vol. 78 Issue 11, p1193 

    Barrett's esophagus is a pathologic change of the normal squamous epithelium of the esophagus to specialized columnar metaplasia. Barrett's esophagus is a result of prolonged exposure of the esophagus to gastroduodenal refluxate. Although Barrett's itself is not symptomatic, and, in fact,...

  • Surgical Treatment of Barrett's Esophagus: 1980-2003. Csendes, Attila // World Journal of Surgery;Mar2004, Vol. 28 Issue 3, p225 

    Barrett's esophagus is a complication of long-standing gastroesophageal reflux and can be a premalignant condition. The goals of surgical treatment, which were well summarized by DeMeester, have been increased and more detailed by us. They consist of (1) controlling symptoms of gastroesophageal...

  • Prospective Study of Cyclin D1 Overexpression in Barrett's Esophagus: Association With Increased.... Bani-Hani, Kamal; Martin, Iain G. // JNCI: Journal of the National Cancer Institute;08/16/2000, Vol. 92 Issue 16, p1316 

    Examines the risk of developing esophageal adenocarcinoma in cyclin D1 overexpression among patients with Barrett's esophagus. Morphological changes in Barrett's esophagus; Genetic alteration in esophageal adenocarcinoma; Significance of cyclin D1 and p53 biomarkers in detecting progression of...

  • The length of newly diagnosed Barrett's esophagus and prior use of acid suppressive therapy. El-Serag, Hashem B; Aguirre, Thomas; Kubeler, Mark; Sampliner, Richard E // American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS5 

    An abstract of the article "The Length of Newly Diagnosed Barrett's Esophagus and Prior Use of Acid Suppressive Therapy," by Hashem B. El-Serag, Thomas Aguirre, Mark Kubeler, and Richard E. Sampliner is presented.

  • Successful Elimination of Reflux Symptoms Does Not Insure Adequate Control of Acid Reflux in Patients with Barrett's Esophagus. Katzka, David A.; Castell, Donald O. // American Journal of Gastroenterology;Jul1994, Vol. 89 Issue 7, p989 

    Objective: Patients with Barrett's metaplasia of the esophagus often lack the appropriate amount of heartburn for their severity of gastroesophageal reflux. Therefore, we studied patients with Barrett's metaplasia by prolonged ambulatory pH monitoring after completely suppressing their heartburn...

  • Barrett's Esophagus--What Should I Know About It?  // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2120 

    Provides information on Barrett's esophagus. Disadvantage of too much stomach acid; Association of gastroesophageal reflux disease with Barrett's esophagus; Use of proton pump inhibitors for treating Barrett's esophagus.

  • Adenocarcinoma in Childhood Barrett's Esophagus: Case Documentation and the Need for Surveillance in Children. Hassall, Eric; Dimmick, James E.; Magee, J. Fergall // American Journal of Gastroenterology;Feb1993, Vol. 88 Issue 2, p282 

    A 17-yr-old boy underwent esophagectomy for multifocal high-grade dysplasia and adenocarcinoma complicating Barrett's esophagus (BE). He is believed to be the first child or young adult to have prolonged healthy survival following resection of esophageal adenocarcinoma. Dysplasia in a short...

  • Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus. Umansky, Mark; Yasui, Waturu; Hallak, Aharon; Brill, Shlomo; Shapira, Itzhak; Halpern, Zamir; Hibshoosh, Hanina; Rattan, Jacob; Meltzer, Stephen; Tahara, Eichii; Arber, Nadir // Oncogene;11/29/2001, Vol. 20 Issue 55, p7987 

    Neoplastic progression in Barrett's esophagus is a multi-step process in which the metaplastic columnar epithelium sequentially evolves through a metaplasia-dysplasia-carcinoma sequence. The expression and DNA copy number of key cell cycle regulatory genes in paired normal and Barrett's...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics